ARTICLE | Company News
Cempra grants Toyama Japanese rights to solithromycin
May 14, 2013 12:26 AM UTC
Cempra Inc. (NASDAQ:CEMP) granted Toyama Chemical Co. Ltd. exclusive rights to develop and commercialize solithromycin in Japan. The fluoroketolide/macrolide antibiotic is in Phase III testing to trea...